Cartalax peptide profile image
Cartalax peptide profile image
Experimental💪Tissue Repair

Cartalax

Also known as: Cartilage Bioregulator

MW

303.30 Da

Routes

3 routes

Cartalax is a synthetic tripeptide (Ala-Glu-Asp) developed by Professor Khavinson as a cartilage-targeted peptide bioregulator. Part of the Khavinson peptide bioregulator series, cartalax is designed to normalize cartilage extracellular matrix metabolism by promoting chondrocyte function and glycosaminoglycan synthesis. Preclinical studies suggest chondroprotective effects including enhanced cartilage matrix production, reduced degradative enzyme activity, and improved joint function in osteoarthritis models.

Research Use Only— For educational and research purposes only
Last updated:

Research Applications

Osteoarthritis research. Cartilage regeneration. Joint health optimization in aging.

Mechanism of Action

Cartalax interacts with DNA regulatory regions in chondrocytes, modulating gene expression related to cartilage matrix synthesis (aggrecan, type II collagen) and degradation (MMP-13, ADAMTS-5).

Biological Pathways

Cartilage repair, Osteoarthritis, Joint recovery

Dosage Information

Typical dosage ranges for research applications. Always verify with current literature.
Typical Dose
3,000 mcg
Dose Range
2,000 - 5,000 mcg
Frequency
Daily for 8-12 week cycles
Typical Dose
200,000 mcg
Dose Range
200,000 - 400,000 mcg
Frequency
1-2 capsules (200 mg each), 1-2 times daily with meals, 10-30 day cycles
Typical Dose
3,000 mcg
Dose Range
2,500 - 3,500 mcg
Frequency
5-6 drops under tongue, 3-4 times daily, 10-15 min before meals
Dosage Calculator
Calculate precise peptide dosages based on your reconstitution parameters
Dosage calculation parameters
Vial size in milligrams
Reconstitution volume in milliliters
Body weight input
Recommended dose per kg
mcg/kg
Desired dose input
mcg

Calculation Results

Concentration
2.5 mg/ml
Dose Volume
0.1 ml0.100 ml
Insulin Syringe
10 units
Doses per Vial
2020 doses @ 250 mcg

Syringe Fill Level (100u syringe)

05010010.0uunits
0u10.0 / 100 units (10%)100u

Protocols

No protocols featuring this peptide yet.

Browse All Protocols

Side Effects & Precautions

Minimal reported

Research Use Only. This information is for educational and research purposes only. Not intended for medical advice or self-medication.

Research Studies

Short Peptides as Bioregulators

Khavinson V, Linkova N, Diatlova A.

International Journal of Molecular Sciences2021
View Source

Frequently Asked Questions

Cartalax is a synthetic tripeptide (Ala-Glu-Asp) developed by Professor Khavinson as a cartilage-targeted peptide bioregulator. Part of the Khavinson peptide bioregulator series, cartalax is designed to normalize cartilage extracellular matrix metabolism by promoting chondrocyte function and glycosaminoglycan synthesis. Preclinical studies suggest chondroprotective effects including enhanced cartilage matrix production, reduced degradative enzyme activity, and improved joint function in osteoarthritis models.

Cartalax interacts with DNA regulatory regions in chondrocytes, modulating gene expression related to cartilage matrix synthesis (aggrecan, type II collagen) and degradation (MMP-13, ADAMTS-5).

Osteoarthritis research. Cartilage regeneration. Joint health optimization in aging.

Cartilage repair, Osteoarthritis, Joint recovery

Minimal reported

Dosage Calculator
Calculate reconstitution volumes and injection amounts for Cartalax.
Open Calculator
Explore More
Explore more peptides in the Tissue Repair category and related research.
View Tissue Repair Category